ATR stock

AptarGroup Inc (ATR) support and resistance · P/E 21, rev $2.01B

AptarGroup Inc (ATR) is a medical instruments & supplies company listed on NYSE.

This page maps AptarGroup Inc (ATR) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported ATR revenue for 2026-06-30 was $2.01B. Net income was $160.2M. ATR currently screens at market cap $7.66B and trailing P/E 20.5.

ATR currently screens at market cap $7.66B and trailing P/E 20.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new ATR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the ATR quote page for the session range and the stock page for the full model.

Not investment advice.

Full ATR analysis